Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.
As part of a $10 million investment in 2024, new production lines for needles and syringes have been installed at BD’s plants in Connecticut and Nebraska, with one line already operational, according to a Jan. 15 news release from the company.
BD is also investing $30 million in 2025 to expand IV catheter production at its Utah facility, following a $2 million investment in 2024 that increased output by 40 million IV catheters per year.
A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by…
DHL Express announced a temporary suspension of business-to-consumer shipments valued over $800 to private individuals in the U.S., effective April…
The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected…
Comments are closed.
